AKT inhibitor VIII
Catalog Number | Pack Size | List Price* | Quantity | |
---|---|---|---|---|
HY-10355-5MG | 5 mg | 181,00 | Add | |
HY-10355-1ML | 10mM/1mL | 217,00 | Add | |
HY-10355-10MG | 10 mg | 254,00 | Add | |
HY-10355-50MG | 50 mg | 710,00 | Add | |
HY-10355-100MG | 100 mg | 1'100,00 | Add | |
HY-10355-S-1ST | Sample | Inquire |
* CHF, excl. 8.1% VAT and shipping costs
Product Description
Best price guarantee – we offer you the lowest price in Switzerland. Please contact us for a quote if needed.
AKT inhibitor VIII (AKTi-1/2) is a cell-permeable quinoxaline compound that has been shown to potently, selectively, allosterically, and reversibly inhibit Akt1, Akt2, and Akt3 activity with IC50s of 58 nM, 210 nM, and 2119 nM, respectively.
Category | Inhibitor |
Supplier | MedChem Express |
Regulatory Status | RUO |
Research Field | Cancer, Metabolic Disease, Apoptosis,PI3K/Akt/mTOR |
Format | Solubility: DMSO : 20 mg/mL (ultrasonic) |
Grade | Clinical information: No Development Reported |
Purity | 98.97% |
Molecular Formula | C34H29N7O |
Molecular Weight | 551.64 |
CAS-Number | 612847-09-3 |
Storage Conditions | -20°C, 3 years; 4°C, 2 years (Powder) |
Tech. Data Sheet | View datasheet |
Link To Supplier | http://www.medchemexpress.com |
Shipping Details | Room Temperature |
Material Safety Data Sheet | Download PDF |